|
R&D Leaders' Forum
Dr Robert Ruffolo, President, Research & Development, Wyeth Pharmaceuticals, Senior Vice President, Wyeth Corporation
Lee E. Babiss, PhD, Head of Global Pharma Research, Roche
Professor Jackie Hunter,Senior Vice President, Science Environment Development, GlaxoSmithKline
Professor Mikael Dolsten, Private Equity Partner, OrbiMed
Dr Robert Booth, Operating Partner, TPG Ventures & Executive Chairman, ViroBay, Inc
Dr Christine J. Cioffe, Vice President, Strategic & Enterprise-wide Portfolio Management, Merck & Co, Inc
Hartmut J. Ehrlich, MD, Vice President, Global R&D, Baxter BioScience
Dr Nicholas Dracopoli, Vice President, Biomarkers & Translational Research, Johnson & Johnson
Dr Nahed Ahmed, Vice President, Program Management & Strategic Operations, Amgen, Inc
Dr Wayne A. Rosenkrans, Director, External Relations, Evidence-based Medicine & Personalized Healthcare, AstraZeneca
Dr David Hughes, Managing Director, Future Drugs Ltd
|
Oncology Leaders' Forum
Dr Mike Owen, Senior Vice President & Head of the Biopharmaceuticals Center of Excellence for Drug Discovery, GlaxoSmithKline
Dr Richard Gaynor, Vice President, Cancer Research & Clinical Investigation, Eli Lilly and Company
Dr Roy Baynes, Vice President, Clinical Development, Therapeutic Area Head, Oncology Supportive Care, Amgen, Inc
Dr Howard Fingert, Senior Director, Clinical Lead, Signal Transduction Development Program, Pfizer Oncology, Pfizer Global R&D
H. Kim Lyerly, MD, Director, Duke Comprehensive Cancer Center
Dr David Urdal, Chief Scientific Officer, Dendreon Corporation
Thomas G. Roberts, MD, MSocSci, Senior Health Care Analyst & Portfolio Manager, Noonday Asset Management, LP (sub-adviser to Farallon Capital Management, LLC)
Roberto Solari, Chief Executive Officer, Medical Research Council Technology
Michael G. McCully. Director & Senior Analyst, Recombinant Capital
Pat Stanfill Edens, RN, PhD, FACHE, FAAMA, Principal, Global Oncology
|
